Top Stories & Key Reads of the Week

Offering Opioid Use Disorder Medication in Jail Reduces Risk of Rearrest After Release

A new study finds people with opioid use disorder (OUD) who are incarcerated and receive the opioid addiction medication buprenorphine are less likely to be rearrested and reconvicted after they are released.

Share Tweet

Snapchat Announces Change Designed to Reduce Illicit Substance Sales

Snapchat announced a change this week to its friend recommendation feature to make it more difficult for people selling illicit substances to connect with minors under 17, NBC News reports.

Share Tweet

E-Cigarette Use Linked with More Symptoms in People with COVID-19

People who vape and test positive for COVID-19 are more likely to have symptoms compared with people who test positive and don’t use e-cigarettes, a new study finds.

Share Tweet

 

Partnership in the News

 

Policy News Roundup

Find more of our must-reads in policy news, including a study on providing buprenorphine in jail to help reduce recidivism.

Share Tweet

Research News Roundup

View our curated digest of the latest research news, including the association between the concurrent use of e-cigarettes and cannabis with COVID-19 symptoms, testing and diagnosis among college student e-cigarette users.

Share Tweet

 

Other Headlines of Interest

Overdose deaths hit a historic high in 2020. Frustrated experts say these strategies could save lives (PBS)


There is life after addiction. Most people recover (NPR)


An Anti-overdose Drug Is Getting Stronger. Maybe That’s a Bad Thing? (The Atlantic)